HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Sustiva (Efavirenz, Stocrin)

The Basics | News | Research | Personal Accounts

Hide Archived (Historical) Articles

Brand Names:	Sustiva, Stocrin
Generic Name:	Efavirenz, EFV
Adult Single Dose:	One 600-mg tablet (once a day)
Food & Liquid Restrictions:	Take on an empty stomach, preferably at bedtime
Drug Class:	NNRTI

From The Body's "Ask the Experts" Forums

I am taking Sustiva + Combivir, and I want to be as adherent as possible. What's the best and easiest way to schedule my doses?
My doctor has me taking Sustiva even though I've shown resistance to it. Is it doing me any good to still be taking this med? Can I switch to another NNRTI?
I had some horrible side effects the first few weeks I was on Sustiva. Since then they've cleared up almost completely, and the treatment caused a huge drop in my viral load. So hang in there!

» More questions

The Basics

An Overview of Sustiva (Efavirenz, Stocrin) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
FAQs About Sustiva (Efavirenz, Stocrin) From The Body's "Ask the Experts" Forums (Regularly Updated)
From The Body's "Ask the Experts" Forums
Efavirenz (Sustiva) (August 22, 2009)
To read PDF, click here
From AIDS InfoNet
Sustiva (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Patient Information About Sustiva (Efavirenz, Stocrin) (PDF) (March 2008)
From Bristol-Myers Squibb Company
Sustiva (Efavirenz) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Important Update to Sustiva Package Insert (January 31, 2007)
From U.S. Food and Drug Administration
Sustiva (Efavirenz) (May 2005)
To read PDF, click here
From The Center for AIDS
Drug Interactions: Efavirenz (August 2004)
[Archived Article]
From Project Inform
Efavirenz (Sustiva) (May 2004)
[Archived Article]
From U.S. Food and Drug Administration
Dizzy, Dreamy, Depressed: Dealing With Sustiva Side Effects (July/August 2003)
[Archived Article]
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Does Viramune = Sustiva? (May/June 2003)
[Archived Article]
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Tips and Tricks on Taking Sustiva (Efavirenz) (September 8, 2002)
[Archived Article]
From AIDSMeds.com
Taking Sustiva? Things You Should Know (Spring 1999)
[Archived Article]
In Women Alive Newsletter, from Women Alive
Sustiva Consumer Information (October 6, 1998)
[Archived Article]
From U.S. Food and Drug Administration
Sustiva a Day (October 1998)
[Archived Article]
From Treatment Action Group
Another Expensive Drug for Your Cocktail (September 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis

News

Efavirenz Treatment and False-Positive Results in Benzodiazepine Screening Tests (June 15, 2009)
In Clinical Infectious Diseases
A Cheaper, Safer Sustiva? Gates Foundation to Fund Trials of Lower HIV Drug Doses (April 29, 2009)
From aidsmap.com
Reyataz and Sustiva Co-Pay Benefit Program (April 16, 2009)
If you live in the U.S., you might be eligible for a benefits program created to help people who are already insured, but still need help to pay for Reyataz or Sustiva.
From Bristol-Myers Squibb Company
South African Addicts Turn to AIDS Medication to Get High (July 7, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Brazilian President Silva Issues Compulsory License for Merck's Antiretroviral Efavirenz (May 7, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Important Update to Sustiva Package Insert (January 31, 2007)
From U.S. Food and Drug Administration
Pregnancy Risk Category Raised for Efavirenz (Summer 2005)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Efavirenz-Associated Neural Tube Defects Reported in Infants; Pregnancy Category Changed From C to D (March 31, 2005)
[Archived Article]
From U.S. Food and Drug Administration
Efavirenz, Stavudine Demand May Soon Exceed Supply in Developing World (March 4, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune (November 23, 2004)
[Archived Article]
A brief comment on the recently issued warning that both regimens frequently fail.
In AIDS Treatment News, from AIDS Treatment News
Merck to Cut Cost of AIDS Drug in Poorest Nations (October 23, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
FDA Approves Once-Daily Efavirenz Formulation, Revised Labeling (March 8, 2002)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
New Formulation of Sustiva Available (March 2002)
[Archived Article]
In What's New, from Project Inform
Sustiva (Efavirenz) in New Formulation (February 8, 2002)
[Archived Article]
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
Sustiva Seems to Cause Prisoners to Wrongly Test Positive for Marijuana Use (November/December 2001)
[Archived Article]
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Nelfinavir, Efavirenz, or Both After the Failure of Nucleoside Treatment of HIV Infection (August 9, 2001)
[Archived Article]
In New England Journal of Medicine
Efavirenz (Sustiva^®): Oral Liquid Expanded Access Program for Children and Adolescents Ages 3-16 (May 5, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
Efavirenz Reduces Lopinavir Levels (May 2000)
[Archived Article]
In What's New, from Project Inform
Efavirenz and Marijuana Tests (April 2000)
[Archived Article]
In What's New, from Project Inform
The High Cost of Fighting HIV (December 1998)
[Archived Article]
DuPont's pricing of Sustiva.
In Body Positive, from Body Positive
Efavirenz (Sustiva^TM) Available Through Patient Assistance Program (November 6, 1998)
[Archived Article]
From AIDS Treatment News
Efavirenz (Sustiva™) Approved (October 2, 1998)
[Archived Article]
From AIDS Treatment News
Access to Efavirenz and Amprenavir (October 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
FDA Approves New Drug to Treat HIV, AIDS (September 18, 1998)
[Archived Article]
From U.S. Food and Drug Administration
What Price Efavirenz? (September 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Efavirenz's Complications (May 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Notice on Efavirenz and Pregnancy (April 3, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
Efavirenz Pregnancy Warning (March 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Efavirenz (Sustiva) Expanded Access Begins October 1 (September 19, 1997)
[Archived Article]
From AIDS Treatment News
DMP 266 Now Available (September 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis

Personal Accounts

Life After Sustiva: Depression, Anxiety Side Effects (May/June 2004)
[Archived Article]
Gerry Hoyt is one of a small number of people who suffer severe, long-term psychological side effects while using efavirenz.
In Survival News, from AIDS Survival Project
Sustiva Electric Dreams (March/April 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Sustiva -- Personal Experiences (January 2000)
In Survival News, from AIDS Survival Project

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.